SNOA
Sonoma Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.45
+0.00 +0.20%
🌙 3월 13일 4:18 PM ET (한국 3/14 05:18)
$2.50
+0.04 ▲ +1.83%
| Index | - | P/E | - | EPS (ttm) | -2.04 | Insider Own | 1.23% | Shs Outstand | 0.00B | Perf Week | 3.15% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | -13.86% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 6.29% | Short Float | 0.76% | Perf Quarter | -34.62% |
| Income | -0.00B | P/S | 0.24 | EPS this Y | - | Inst Trans | 3.56% | Short Ratio | 0.73 | Perf Half Y | -46.04% |
| Sales | 0.02B | P/B | 1.24 | EPS next 5Y | - | ROA | -24.7% | Short Interest | 0.01M | Perf YTD | -32.55% |
| Book/sh | 1.98 | P/C | 1.66 | EPS past 3/5Y | 58.27% 42.62% | ROE | -81.19% | 52W High | -64.52% ($6.92) | Perf Year | -20.29% |
| Cash/sh | 1.48 | P/FCF | - | Sales past 3/5Y | 4.2% -4.44% | ROIC | -85.51% | 52W Low | 40.29% ($1.75) | Perf 3Y | -86.99% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 48.18% | Gross Margin | 38.16% | Volatility(W/M) | 6.83% 5.65% | Perf 5Y | -98.33% |
| Dividend TTM | - | EV/Sales | 0.13 | Sales Y/Y TTM | 26.83% | Oper. Margin | -15.61% | ATR (14) | 0.17 | Perf 10Y | -99.76% |
| Dividend Ex-Date | - | Quick Ratio | 1.97 | EPS Q/Q | 24.58% | Profit Margin | -19.02% | RSI (14) | 35.46 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.84 | Sales Q/Q | 22.03% | SMA20 | -9.6% ($2.71) | Beta | 1.71 | Target Price | $12 |
| Payout | - | Debt/Eq | 0.19 | Earnings | 2000000 | SMA50 | -20.42% ($3.08) | Rel Volume | 0.14 | Prev Close | $2.45 |
| Employees | 168 | LT Debt/Eq | 0.15 | EPS/Sales Surpr. | -21.24% -20.55% | SMA200 | -30.94% ($3.55) | Avg Volume(3M) | 0.02M | Price | $2.45 |
| IPO | 2007/1/25 | Option/Short | No/Yes | Trades | 31 | Volume | 2,483 | Change | 0.2% |
뉴스 로딩 중...